Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.07.21	Lilly Announces Acquisition of Protomer Technologies (PR Newswire)
09.07.21	Lilly: Mirikizumab In Trial Up-Regulates Genes Associated With Mucosal Healing In UC For Upto 1 Year (RTTNews)
09.07.21	Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerative Colitis for Up to One Year in Phase 2 Study (PR Newswire)
06.07.21	Eli Lilly Says EMPEROR-Preserved Phase III Trial Of Jardiance Met Primary Endpoint - Quick Facts (RTTNews)
06.07.21	Breakthrough results for Jardiance® (empagliflozin) confirm EMPEROR-Preserved as first and only successful trial for heart failure with preserved ejection fraction (PR Newswire)
29.06.21	Lilly Declares Third-Quarter 2021 Dividend (PR Newswire)
28.06.21	Pre-market Movers: NTLA, ABUS, ATOS, GTEC... (RTTNews)
26.06.21	Lilly's SURPASS-1 results published in The Lancet show tirzepatide's superior A1C and body weight reductions versus placebo in adults with type 2 diabetes (PR Newswire)
25.06.21	Lilly's SURPASS-2 results published in The New England Journal of Medicine show tirzepatide achieved superior A1C and body weight reductions compared to injectable semaglutide in adults with type ... (PR Newswire)
24.06.21	Lilly announces call for Leonard Award nominations as part of global initiative celebrating 100 years of insulin (PR Newswire)
24.06.21	Lilly's Donanemab For Alzheimer's Disease Gets Breakthrough Therapy Designation (RTTNews)
24.06.21	Lilly's donanemab receives U.S. FDA's Breakthrough Therapy designation for treatment of Alzheimer's disease (PR Newswire)
24.06.21	Biotech Stocks Facing FDA Decision In July 2021 (RTTNews)
17.06.21	Lilly Launches Think Talk Treat Migraine™ to Help Improve Diagnosis and Treatment of Migraine (PR Newswire)
15.06.21	Eli Lilly To Launch Head-to-head Study Comparing Once-monthly Injectable Emgality With Nurtec ODT (RTTNews)
15.06.21	Lilly Announces Head-to-Head Study Comparing Once-Monthly Emgality® with Every-Other-Day Nurtec® ODT for the Preventive Treatment of Migraine (PR Newswire)
14.06.21	Lilly to Participate in Guggenheim Biopharma Strategy Series (PR Newswire)
11.06.21	Lilly Announces Webcast to Provide Diabetes Portfolio Update at ADA (PR Newswire)
10.06.21	ALX Oncology Inks Clinical Trial Collaboration Supply Deal With Eli Lilly For ALX148 Combination (RTTNews)
27.05.21	Eli Lilly Reveals Receipt Of Subpoena From DoJ On Branchburg Manufacturing Facility - Quick Facts (RTTNews)
20.05.21	Lilly's Diabetes Drug Candidate Tirzepatide Meets Primary Study Outcome In Surpass-4 Trial (RTTNews)
18.05.21	Hershey To Buy Lily's Confectionery Brand - Quick Facts (RTTNews)
11.05.21	Eli Lilly, MiNA Therapeutics To Collaborate On Research Using MiNA's SaRNA Technology - Quick Facts (RTTNews)
04.05.21	Lilly Outlines Plans To Strengthen ESG Commitments (RTTNews)
04.05.21	Lilly To Donate COVID-19 Treatment Baricitinib To India - Quick Facts (RTTNews)
27.04.21	Lilly Q1 Profit Down; Cuts FY Profit View (RTTNews)
27.04.21	Eli Lilly And Co. Q1 adjusted earnings of $1.87 per share (RTTNews)
23.04.21	Incyte : Olumiant Shows Improvements In Severity And Extent Of Atopic Dermatitis (RTTNews)
20.04.21	Eli Lilly Says 2nd Late-stage Study Of Baricitinib Achieved Main Goal- Quick Facts (RTTNews)
16.04.21	Eli Lilly Requests FDA Revoke EUA For Bamlanivimab 700 Mg Alone - Quick Facts (RTTNews)
13.04.21	Eli Lilly Appoints Diogo Rau To Head Information Technology And Digital Capabilities (RTTNews)
13.04.21	Lilly : Phase 3 Study Shows Sintilimab Improves OS For Squamous Non-small Cell Lung Cancer Patients (RTTNews)
12.04.21	Eli Lilly, U.S. Government Amend Purchase Agreements For Neutralizing Antibody Therapies (RTTNews)
08.04.21	Eli Lilly Says Late-stage Study Of Baricitinib In Hospitalized Covid Patients Didn't Meet Main Goal (RTTNews)
29.03.21	Lilly, Vir And GSK Announce Positive Data From Phase 2 BLAZE-4 Trial On COVID-19 (RTTNews)
23.03.21	AZN's COVID-19 Jab Shows 79% Efficacy, ZEAL Wins FDA Approval, AdComm To Review Osteoarthritis Drug (RTTNews)
17.03.21	Lilly Reports Patient-Reported Outcomes From Phase 3 MonarchE Trial For Verzenio (RTTNews)
17.03.21	CELC Inks Breast Cancer Trial Collaboration, CANF Soars On Deal With Ewopharma, MRUS On Watch (RTTNews)
10.03.21	Lilly' Bamlanivimab & Etesevimab Reduce Hospitalizations & Death In Phase 3 Trial For Early COVID-19 (RTTNews)
09.03.21	Eli Lilly: Myles O'Neill And Melissa Barnes To Retire - Quick Facts (RTTNews)
04.03.21	Eli Lilly Announces Positive Topline Results From Late-stage Study Of Tirzepatide- Quick Facts (RTTNews)
03.03.21	Eli Lilly, Incyte Report Positive Results For Baricitinib In Alopecia Areata Treatment- Quick Facts (RTTNews)
03.03.21	Lilly : Phase 3 Study On Baricitinib Meets Primary Endpoint Of Hair Regrowth (RTTNews)
26.02.21	Eli Lilly: U.S. Govt. To Buy Min. 100K Doses Of Bamlanivimab 700 Mg, Etesevimab 1400 Mg Together (RTTNews)
19.02.21	FLXN On Track, IMNM Discovers Antibodies To Fight S. African Variant, RIGL In Deal With LLY (RTTNews)
18.02.21	Lilly, Rigel To Develop RIPK1 Inhibitors For Treatment Of Immunological & Neurodegenerative Diseases (RTTNews)
17.02.21	Eli Lilly: Tirzepatide Significantly Reduced A1C And Body Weight In Two Phase 3 SURPASS Trials (RTTNews)
10.02.21	GMDA On Track, GNFT Soars, HTBX Sparkles, LLY's Neutralizing Antibody Therapies Get FDA Nod (RTTNews)
10.02.21	Lilly's COVID-19 Antibody Combination Receives Emergency Use Authorization In U.S. (RTTNews)
09.02.21	Eli Lilly Appoints Anat Ashkenazi To Succeed Josh Smiley As CFO - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester
22.11.24		Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Deutsche Bank AG: Novartis-Aktie erhält Hold
22.11.24		Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester
22.11.24		Optimismus in Europa: So entwickelt sich der Euro STOXX 50 am Freitagnachmittag
22.11.24		Pluszeichen in Europa: STOXX 50 notiert im Plus

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

SIX-Handel: SLI zeigt sich zum Ende des Freitagshandels fester

22.11.24

Pluszeichen in Zürich: SMI zum Ende des Freitagshandels mit grünem Vorzeichen

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Deutsche Bank AG: Novartis-Aktie erhält Hold

22.11.24

Freitagshandel in New York: Dow Jones zum Start des Freitagshandels fester